Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-03-27 @ 7:53 AM
Study NCT ID:
NCT04645160
Status:
RECRUITING
Last Update Posted:
2025-12-15
First Post:
2020-11-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
210006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None